These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The role of heat shock proteins as chaperones on several human diseases. Mellati AA Saudi Med J; 2006 Sep; 27(9):1302-5. PubMed ID: 16951762 [TBL] [Abstract][Full Text] [Related]
4. Activating or Inhibiting Nrf2? Chu XY; Liu YM; Zhang HY Trends Pharmacol Sci; 2017 Nov; 38(11):953-955. PubMed ID: 28886953 [TBL] [Abstract][Full Text] [Related]
5. Amino acid sequence determinants and molecular chaperones in amyloid fibril formation. Nerelius C; Fitzen M; Johansson J Biochem Biophys Res Commun; 2010 May; 396(1):2-6. PubMed ID: 20494101 [TBL] [Abstract][Full Text] [Related]
6. Pleiotropic Effects of Isoflavones in Inflammation and Chronic Degenerative Diseases. Bernatoniene J; Kazlauskaite JA; Kopustinskiene DM Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073381 [TBL] [Abstract][Full Text] [Related]
7. Applications of Antioxidants in Metabolic Disorders and Degenerative Diseases: Mechanistic Approach. Abdel-Daim MM; El-Tawil OS; Bungau SG; Atanasov AG Oxid Med Cell Longev; 2019; 2019():4179676. PubMed ID: 31467632 [No Abstract] [Full Text] [Related]
8. High throughput screening technology and the small molecules modulating aging related signals. Mo C; Zhang W; Liu L; Wang L; Xiao H Comb Chem High Throughput Screen; 2012 Mar; 15(3):242-52. PubMed ID: 22221057 [TBL] [Abstract][Full Text] [Related]
9. Sick chaperones, cellular stress, and disease. Macario AJ; Conway de Macario E N Engl J Med; 2005 Oct; 353(14):1489-501. PubMed ID: 16207851 [No Abstract] [Full Text] [Related]
10. Chaperones and retinal disorders. Sokolov M; Yadav RP; Brooks C; Artemyev NO Adv Protein Chem Struct Biol; 2019; 114():85-117. PubMed ID: 30635087 [TBL] [Abstract][Full Text] [Related]
12. Metabolomics as a tool for drug discovery and personalised medicine. A review. Mastrangelo A; Armitage EG; García A; Barbas C Curr Top Med Chem; 2014; 14(23):2627-36. PubMed ID: 25515755 [TBL] [Abstract][Full Text] [Related]
13. Molecular Chaperones in Neurodegenerative Diseases: A Short Review. Bobori C; Theocharopoulou G; Vlamos P Adv Exp Med Biol; 2017; 987():219-231. PubMed ID: 28971461 [TBL] [Abstract][Full Text] [Related]
14. Therapeutic use of heat shock proteins and essential factors in prognosis, diagnosis and treatment of neurodegenerative and metabolic diseases. Tutar Y Curr Pharm Biotechnol; 2010 Feb; 11(2):138. PubMed ID: 20230365 [No Abstract] [Full Text] [Related]
15. [Cytosolic protein quality control system--the role of molecular chaperones in the biology of neurodegenerative diseases]. Guenther I; Kedzierska-Mieszkowska S Postepy Biochem; 2011; 57(3):274-82. PubMed ID: 22235653 [TBL] [Abstract][Full Text] [Related]
17. How our bodies fight amyloidosis: effects of physiological factors on pathogenic aggregation of amyloidogenic proteins. Huang L; Liu X; Cheng B; Huang K Arch Biochem Biophys; 2015 Feb; 568():46-55. PubMed ID: 25615529 [TBL] [Abstract][Full Text] [Related]
18. [A comment to the Klaringsrapport nr 6, 2000 "Type 2 diabetes and the metabolic syndrome--diagnosis and treatment"]. Hallager K Ugeskr Laeger; 2000 Sep; 162(36):4824. PubMed ID: 10994385 [No Abstract] [Full Text] [Related]
19. Impact of polyphenols on extracellular vesicle levels and effects and their properties as tools for drug delivery for nutrition and health. Soleti R; Andriantsitohaina R; Martinez MC Arch Biochem Biophys; 2018 Apr; 644():57-63. PubMed ID: 29518372 [TBL] [Abstract][Full Text] [Related]
20. Emerging roles of J proteins in neurodegenerative disorders. Gibbs SJ; Braun JE Neurobiol Dis; 2008 Nov; 32(2):196-9. PubMed ID: 18760363 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]